Biotheranostics launches genomic tests with Next Generation Sequencing for metastatic

[News]

bioTheranostics, Inc., today introduced the bioT3 Metastatic Cancer Solution, a suite of genomic-based tests that provide personalized diagnostic information and therapeutic guidance for metastatic cancer patients across the continuum of care.

More... (http://www.news-medical.net/news/20140204/Biotheranostics-launches-genomic-tests-with-Next-Generation-Sequencing-for-metastatic-cancer-patients.aspx)